Geneart GmbH – Trademark Portfolio
Entity Type: 03
Geneart GmbH holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include GENEART and GENEOPTIMIZER. The owner is based in D-93053 Regensburg.
Josef-Engert-Str. 9
D-93053 Regensburg , DE
Showing of trademarks Trademarks
Trademark Classifications
Geneart GmbH's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Geneart GmbH have?
Geneart GmbH has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.
What trademark classes does Geneart GmbH file in?
Geneart GmbH files trademarks across 4 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Geneart GmbH's most well-known trademarks?
Geneart GmbH's registered trademark portfolio includes well-known marks such as GENEART and GENEOPTIMIZER. These are among 2 currently registered trademarks in the portfolio.
What is Geneart GmbH's trademark registration success rate?
Geneart GmbH has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.